Abcam
Cambridge · United Kingdom LLC · 1 known investors
Supplier of protein research tools to life scientists. Publicly listed on the LSE following an IPO.
Founders & leadership
JS
Jonathan Simon MilnerFounder
AT
Alan Thomas HirzelExecutive
MS
Michael Shaun BaldockNamed on SEC filing
Board
PV
Peter Vance AllenBoard director
MG
Mara Glickman AspinallBoard director
LA
Louise Alexandra Virginia Charlotte PattenBoard director
GF
Giles Francis Bertram KerrBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$800K disclosed across 1 round · 2020
▶$800KraisedMar 2020 · 3 investors · Other Health CareRule 506(b)
▶$800KraisedMar 2020 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Peter Vance AllenDirector
- Mara Glickman AspinallDirector
- Michael Shaun BaldockDirector
- Louise Alexandra Virginia Charlotte PattenDirector
- Giles Francis Bertram KerrDirector
- Jonathan Simon MilnerDirector
- Alan Thomas HirzelDirector
- Offering amount
- $800K
- Amount sold
- $800K
- Minimum investment
- $33.6K
- First sale
- Mar 2020
- Incorporated
- Limited Liability Company, United Kingdom
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Abcam do?
- Supplier of protein research tools to life scientists. Publicly listed on the LSE following an IPO.
- Who founded Abcam?
- Abcam was founded by Jonathan Simon Milner.
- Who are Abcam's investors?
- Abcam's investors include Martlet Capital.
- How much funding has Abcam raised?
- Abcam has disclosed $800K raised across 1 round.
- Where is Abcam headquartered?
- Abcam is headquartered in Cambridge.